This table provides a summary of studies on the duration of protection of COVID-19 vaccines. This table is updated weekly.
-
Results & Summaries
-
VIEW-Hub Reports
The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the
-
Methods
This document outlines the methods used in the COVID-19 vaccines neutralization and cellular immunity studies review.
-
Results & Summaries
In partnership with the Asian Development Bank, IVAC developed factsheets summarizing key measures for COVID-19 vaccines such as effectiveness and protection against severe disease.
-
VIEW-Hub Reports
The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the
-
Results & Summaries
This table summarizes vaccine impact results for COVID-19 studies conducted globally. This table is updated weekly.
-
Results & Summaries
These forest plots summarize available COVID-19 vaccine effectiveness against Delta and Omicron variants by vaccine, disease outcome, and study population.
-
VIEW-Hub Reports
The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the
-
Results & Summaries
This file contains a list of neutralization studies identified from an ongoing systematic review of literature evaluating the impact of SARS-CoV 2 variants of concern on COVID-19 vaccine performance.
-
Results & Summaries
These forest plots summarize available COVID-19 vaccine effectiveness data by vaccine and variant of concern.